Concepedia

Capecitabine and temozolomide (CAPTEM) for metastatic, well-differentiated neuroendocrine cancers: The Pancreas Center at Columbia University experience

Robert L. Fine, Anthony P. Gulati, Benjamin A. Krantz, Rebecca A. Moss, Stephen M. Schreibman, Dawn Tsushima, Kelley B. Mowatt, Richard D. Dinnen, Yuehua Mao, Peter D. Stevens,

Cancer Chemotherapy and Pharmacology · 2013 · 257 citations · 24 references

DOI

Concepts

References

24

Everolimus for Advanced Pancreatic Neuroendocrine Tumors

James C. Yao, Manisha H. Shah, Tetsuhide Ito et al. · New England Journal of Medicine · 2011 · 2.8K citations · Full text

, , +12

Sunitinib Malate for the Treatment of Pancreatic Neuroendocrine Tumors

Éric Raymond, Laëtitia Dahan, Jean‐Luc Raoul et al. · New England Journal of Medicine · 2011 · 2.5K citations

, , +11

Placebo-Controlled, Double-Blind, Prospective, Randomized Study on the Effect of Octreotide LAR in the Control of Tumor Growth in Patients With Metastatic Neuroendocrine Midgut Tumors: A Report From the PROMID Study Group

Anja Rinke, Hans‐Helge Müller, Carmen Schade‐Brittinger et al. · Journal of Clinical Oncology · 2009 · 2.5K citations

, , +17

First‐line chemotherapy with capecitabine and temozolomide in patients with metastatic pancreatic endocrine carcinomas

Jonathan Strosberg, Robert L. Fine, Junsung Choi et al. · Cancer · 2010 · 766 citations · Full text

, , +17

Phase II Study of Temozolomide and Thalidomide in Patients With Metastatic Neuroendocrine Tumors

Matthew H. Kulke, Keith Stuart, Peter C. Enzinger et al. · Journal of Clinical Oncology · 2006 · 518 citations

, , +16